Related Experiment Video

Updated: Aug 7, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Gene therapy of metabolic diseases

Alain Fischer1, Salima Hacein-Bey-Abina, Marina Cavazzana-Calvo

  • 1Inserm, U768, Paris, France. fischer@necker.fr

Journal of Inherited Metabolic Disease
|June 10, 2006
PubMed

Insights

Gene therapy shows promise for metabolic diseases, with successful proof-of-concept in inherited immunodeficiencies. Ongoing research addresses safety concerns and explores strategies for over 20 metabolic disorders, paving the way for clinical trials.

Area of Science:

  • Biomedical research
  • Genetic medicine
  • Metabolic disorders

Background:

  • Metabolic diseases represent a significant health burden.
  • Gene therapy offers a potential curative approach for genetic disorders.
  • Inherited immunodeficiencies have shown initial success with gene therapy.

Purpose of the Study:

  • To review the current state and future potential of gene therapy for metabolic diseases.
  • To identify key challenges and opportunities in applying gene therapy to metabolic disorders.
  • To assess the readiness of gene therapy strategies for clinical translation in metabolic diseases.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of gene therapy strategies for various metabolic diseases.
  • Evaluation of safety data and regulatory considerations.

Main Results:

  • Proof of principle for gene therapy established in two inherited immunodeficiency conditions.
  • A significant safety issue has been identified, requiring careful management.
  • Experimental strategies are under investigation for over 20 distinct metabolic diseases.

Conclusions:

  • Gene therapy holds considerable potential for treating a wide range of metabolic diseases.
  • Addressing safety concerns is paramount for successful clinical translation.
  • Further research and development are crucial for advancing gene therapy in metabolic medicine.

More Related Videos

Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...